NOVALIQ

Serial Number 87943588
Registration 5754982
705

Registration Progress

Application Filed
May 31, 2018
Under Examination
Approved for Publication
Mar 5, 2019
Published for Opposition
Mar 5, 2019
Registered
May 21, 2019

Trademark Image

NOVALIQ

Basic Information

Serial Number
87943588
Registration Number
5754982
Filing Date
May 31, 2018
Registration Date
May 21, 2019
Published for Opposition
March 5, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
705
Status Date
Dec 31, 2025
Registration
Registered
Classes
001 005 041 042

Rights Holder

Novaliq GmbH

99
Address
Im Neuenheimer Feld 515
Heidelberg 69120
DE

Ownership History

Novaliq GmbH

Original Applicant
99
Heidelberg DE

Novaliq GmbH

Owner at Publication
99
Heidelberg DE

Novaliq GmbH

Original Registrant
99
Heidelberg DE

Legal Representation

Attorney
Pina M. Campagna

USPTO Deadlines

Next Deadline
1213 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20190521)
Due Date
May 21, 2029
Grace Period Ends
November 21, 2029

Application History

29 events
Date Code Type Description Documents
Dec 31, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 31, 2025 C15P O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Dec 31, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 26, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
May 21, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 16, 2019 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Jul 11, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 18, 2019 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
May 21, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 13, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 28, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 31, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 31, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 31, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 22, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 22, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 19, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 19, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 9, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 27, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 23, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 7, 2018 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jun 7, 2018 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jun 7, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 4, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
[ (based on 44(e)) Chemical and biochemical preparations used in industry, namely, semifluorinated alkanes as bases for manufacturing medical aids, and for manufacturing pharmaceutical or medical preparations; chemical preparations used in industry, namely, chemical additives for use in the manufacture of pharmaceuticals ]
Class 005
[ (based on 44(e)) Biological, chemical and biochemical preparations for pharmaceutical or medical purposes, namely, ophthalmologic and dermatologic preparations; biological, chemical and biochemical diagnostic preparations for medical use; pharmaceutical preparations, exclusive of medicaments and medicines, namely, for treating skin diseases and disorders; pharmaceutical preparations, exclusive of medicaments and medicines, namely, for treating eye diseases and disorders ]
Class 041
(based on 44(e) with claim of priority under 44(d)) Publishing and issuing scientific papers in relation to medical technology; publishing of electronic publications
Class 042
(based on 44(e) with claim of priority under 44(d)) Pharmaceutical product evaluation, pharmaceutical research services, pharmaceutical product development, conducting early evaluations in the field of new pharmaceuticals

Additional Information

Other
In the statement, line 23, "GERMAN DEMOCRATIC REPUBLIC" should be deleted, and "GERMANY" should be inserted.

Classification

International Classes
001 005 041 042